Fezolinetant
Overview
Fezolinetant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3608680).
API suppliers (4)
Suppliers of Fezolinetant evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- MOEHS IBERICA SLSpain1 active DMF GMP on record
- MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
- Shandong Loncom Pharmaceutical Co.,ltd.China1 active DMF
- AMI LIFESCIENCES PRIVATE LTDIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Fezolinetant expires 28 Mar 2034 and exclusivity 12 May 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
- Canonical SMILES
- C[C@@H]1C2=NN=C(N2CCN1C(=O)C3=CC=C(C=C3)F)C4=NC(=NS4)C
- InChIKey
- PPSNFPASKFYPMN-SECBINFHSA-N
Do you supply Fezolinetant? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.